Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification

Haematologica

Volumn 97, Issue 11, 2012, Pages 1708-1712

  Yan, Lingzhi ^a   Ping, Nana ^a   Zhu, Mingqing ^a   Sun, Aining ^a   Xue, Yongquan ^a   Ruan, Changgeng ^a   Drexler, Hans G ^b   MacLeod, Roderick A F ^b   Wu, Depei ^a   Chen, Suning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

Cytogenetic; Immunophenotype; Mixed phenotype acute leukemia; Mutation; Therapy

Indexed keywords

ACLARUBICIN; CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IKAROS TRANSCRIPTION FACTOR; K RAS PROTEIN; LYMPHOID ENHANCER FACTOR 1; MITOXANTRONE; MYOCYTE ENHANCER FACTOR 2; NOTCH1 RECEPTOR; POLYCOMB GROUP PROTEIN; PREDNISONE; TRANSCRIPTION FACTOR 3; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE; VINDESINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIXED PHENOTYPE ACUTE LEUKEMIA; MONOSOMY 7; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHENOTYPE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRISOMY 8;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 84868560506     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.064485     Document Type: Article

References (24)

1. Mirro J, Zipf TF, Pui CH, Kitchingman G, Williams D, Melvin S, et al. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood. 1985;66(5):1115-23.
2. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Marín-López A. The incidence of hybrid acute leukaemias. Leuk Res. 1988;12(9):707-9.
3. Weir EG, Ali Ansari-Lari M, Batista DA, Griffin CA, Fuller S, Smith BD, et al. Acute bilineal leukemia: a rare disease with poor outcome. Leukemia. 2007;21(11):2264-70.
4. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, et al. Definition of acute biphenotypic leukemia. Haematologica. 1997;82(1):64-6.
5. Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010;24(11): 1844-51.
6. Borowitz MJ, Bene MC, Harris NL, Porwit A, Matutes E. Acute leukemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008, pp 150-5.
7. Zhang Y, Wu D, Sun A, Qiu H, He G, Jin Z, et al. Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series. Acta Haematol. 2011;125(4):210-8.
8. Al-Seraihy AS, Owaidah TM, Ayas M, El-Solh H, Al-Mahr M, Al-Ahmari A, et al. Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica. 2009;94(12):1682-90.
9. Xu XQ, Wang JM, Lü SQ, Chen L, Yang JM, Zhang WP, et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica. 2009;94(7):919-27.
10. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital. Blood 2009;113(21):5083-9.
11. Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, et al. Outcome of biphenotypic acute leukemia. Haematologica. 1999;84(8):699-706.
12. Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein overexpression. Br J Haematol. 1998;100(1):147-55.
13. Owaidah TM, Beihany AA, Lqbal MA, Elkum N and Roberts GT. Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia. 2006;20(4):620-6.
14. Matutes E, Pickl WF, Van't Veer M, Morilla R, Swansbury J, Strobl H, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117(11):3163-71.
15. Strehl S, König M, Mann G, Haas OA. Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia. Blood. 2001;97(3): 805-8.
16. Pan Q, Zhu YJ, Gu BW, Cai X, Bai XT, Yun HY, et al. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del (3)(q29) translocation. Oncogene. 2008;27 (24):3414-23.
17. Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood. 2007;109 (11):4641-7.
18. Larsson N, Lilljebjörn H, Lassen C, Johansson B, Fioretos T. Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations. Eur J Haematol. 2012;88(2):136-43.
19. Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010;116 (23):4874-84.
20. Lundin C, Hjorth L, Behrendtz M, Nordgren A, Palmqvist L, Andersen MK, et al. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome. Genes Chromosomes Cancer. 2012;51(2):196-206.
21. Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011;118(23):6153-63.
22. Tang JL, Hou HA, Chen CY, Liu CY, Chou WC, Tseng MH, et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 2009;114(26):5352-61.
23. Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S, et al. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood. 2010;115(14): 2845-51.
24. Nagel S, Meyer C, Quentmeier H, Kaufmann M, Drexler HG, MacLeod RA, et al. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia. 2008;22 (3):600-7.